Related Experiment Video
Updated: Jun 18, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Telavancin: a novel lipoglycopeptide
Louis D Saravolatz1, Gary E Stein, Leonard B Johnson
1St John Hospital and Medical Center, Detroit, Michigan, USA. louis.saravolatz@stjohn.org
Telavancin is an effective lipoglycopeptide antibiotic for treating skin infections and pneumonia, including resistant strains. Clinical trials show it is non-inferior to vancomycin but has a different side effect profile.
Area of Science:
- Pharmacology
- Infectious Diseases
- Microbiology
Background:
- Telavancin is a lipoglycopeptide antibiotic.
- It is a derivative of vancomycin.
- It is used to treat complicated skin and skin-structure infections and gram-positive pneumonia.
Purpose of the Study:
- To evaluate the efficacy and safety of Telavancin.
- To compare Telavancin with vancomycin.
- To assess Telavancin's activity against resistant strains of Staphylococcus aureus.
Main Methods:
- Clinical trials were conducted.
- Efficacy and safety data were collected.
- Comparative analysis with vancomycin was performed.
Main Results:
- Telavancin demonstrated non-inferiority to vancomycin in treating skin infections and pneumonia.
- Telavancin showed consistent activity against various resistant strains of Staphylococcus aureus.
- Adverse events included higher rates of renal events, altered taste, nausea, and vomiting compared to vancomycin, but lower rates of pruritus and infusion-related events.
Conclusions:
- Telavancin is a viable treatment option for complicated skin infections and pneumonia.
- Telavancin possesses a favorable activity spectrum against resistant Staphylococcus aureus.
- The safety profile of Telavancin necessitates careful monitoring, particularly for renal function.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antimicrobial Effectiveness
Gram-negative Bacterial Protein Secretion Systems

